Dr. Eva Grunfeld is a leader in cancer health services and outcomes research. Her research focuses on evaluation and knowledge translation of cancer health services, covering the entire spectrum of cancer control activities. She is internationally recognized for research on cancer survivorship.
Dr. Grunfeld uses a mixed-methods approach including randomized controlled trials, qualitative research and outcomes research. Knowledge translation is an integral part of all her research activities. She has conducted several multi-centre RCTs on cancer survivorship which has influenced clinical practice guidelines and policies internationally.
Dr. Grunfeld holds many peer-review grants as Principal Investigator and has served on many committees to further the goals of cancer control in Canada and internationally. She obtained her medical degree from McMaster University and doctoral degree in cancer epidemiology from Oxford University.
Recently, Dr. Grunfeld was appointed Chair of the Chronic Conditions Institute Advisory Board (IABs) for The Canadian Institutes of Health Research (CIHR). Dr. Eva Grunfeld has been selected as the Chair to provide advice on accelerating the discovery, development, evaluation and integration of solutions that enable Canadians living with chronic conditions to continue to participate actively in society. IAB members represent the highest standard of excellence across CIHR’s four research areas (biomedical; clinical; health systems and services; and the social, cultural and environmental factors that affect the health of populations).
DPhil, Epidemiology, Oxford University, 1997
MD, McMaster University, 1986
MSc, Nutrition, University of Guelph, 1981
- Recipient, 2014 ICRF, Scientific Honoree, Toronto, Ontario (Research Award)
- Outstanding Contribution to Family Medicine Research, Department of Family and Community Medicine, University of Toronto (2013)
- Career Scientist, Ontario Ministry of Health (1995-2000; 2000-2005)
- Knowledge translation
- Cancer survivorship
- End-of-life care
- Coordination and quality of cancer care